Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

DOXEN-DT

Class 5Status: Opposed
Application Number4003423
Trademark Status
Opposed
Trademark Class5
Application Date2018-11-21
Proprietor NameGOPAL MAHESHWARI PROPRIETORS OF BRISKO LAB
Appropriate OfficeMUMBAI
StateMADHYA PRADESH
Trademark TypeWORD
User DetailsProposed to be used
Agent NameMAA SHARDA ASSOCIATES[25030]
Agent Address7/1 RACE COURSE ROAD NEW PALASIA , 214 RATNAMANI COMPLEX INDORE 452001
Goods And Services Details[CLASS : 5] PHARMACEUTICALS AND MEDICINAL PREPRATIONS;

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
DOXEN-DT5Opposed
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about DOXEN DT.

What is the status of trademark application 4003423?
The current status of trademark application 4003423 for DOXEN-DT is Opposed.
What is the trademark class of DOXEN-DT?
DOXEN-DT is registered under trademark class 5.
Who is the proprietor of DOXEN-DT?
The proprietor of DOXEN-DT is GOPAL MAHESHWARI PROPRIETORS OF BRISKO LAB.
When was trademark application 4003423 filed?
Trademark application 4003423 for DOXEN-DT was filed on 2018-11-21.